Elicio Therapeutics Presents Updated Preliminary Data Includ

Elicio Therapeutics Presents Updated Preliminary Data Including Promising Relapse-Free Survival Data from the Phase 1 Study of ELI-002 at AACR Special Conference: Pancreatic Cancer

Elicio Therapeutics Presents Updated Preliminary Data Including Promising Relapse-Free Survival Data from the Phase 1 Study of ELI-002 at AACR Special Conference: Pancreatic Cancer

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , Massachusetts Institute Of Technology , Christopher Haqq , Heather Divecchia , Gloria Gasaatura , Eileenm Oreilly , Eileen Oreilly , Securities Exchange , Pancreatic Cancer Research , Head Of Research , Memorial Sloan Kettering Cancer Center , Elicio Therapeutics Inc , Lifesci Communications , Davidm Rubenstein Center , Nasdaq , Relapse Free Survival , Pancreatic Cancer , Winthrop Rockefeller Endowed Chair , Medical Oncology , Medical Initiatives , Section Head , Neuroendocrine Cancers , Executive Vice President , Chief Medical Officer , Minimal Residual Disease , Poster Session , Eileeno Reilly , Response Evaluation Criteria , Solid Tumors , Massachusetts Institute , Securities Exchange Act , Private Securities Litigation Reform Act ,